Aurinia Pharmaceuticals Inc

(AUPH) Trade

By |

Profile

Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing voclosporin, an investigational drug, for the treatment of lupus nephritis (LN), focal segmental glomerulosclerosis (FSGS), and Dry Eye Syndrome (DES). Geographically, it derives maximum revenue from the United States followed by China.

Contact Information

Website: www.auriniapharma.com
Email: dbourgeault@auriniapharma.com
Main Phone: +1 250 708-4272
Address: 4464 Markham Street
Address 2: Suite 1203
State: BC
City / Town: Victoria
Country: CA
Postal Code: V8Z 7X8

Issuer Information

Exchange: NSD
CEO: Peter S. Greenleaf
Employees: 62
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

Profile

Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing voclosporin, an investigational drug, for the treatment of lupus nephritis (LN), focal segmental glomerulosclerosis (FSGS), and Dry Eye Syndrome (DES). Geographically, it derives maximum revenue from the United States followed by China.

Contact Information

Website: www.auriniapharma.com
Email: dbourgeault@auriniapharma.com
Main Phone: +1 250 708-4272
Address: 4464 Markham Street
Address 2: Suite 1203
State: BC
City / Town: Victoria
Country: CA
Postal Code: V8Z 7X8

Issuer Information

Exchange: NSD
CEO: Peter S. Greenleaf
Employees: 62
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

$ 15.42 $ -0.24 (-1.53%)
Last Price 15.42 Change $ -0.24 Change % -1.53 Tick N/A
Bid 15.42 Bid Size 400.00 Ask 15.90 Ask Size 100.00
Open 15.53 High 15.89 Low 15.23 Prev Close 15.66
Last Trade Volume 596,251 52 Wk Hi 21.94 52 Wk Low 4.66
Market Cap 1.9 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 126,449,513.00 EPS (TTM) N/A PE Ratio N/A Exchange NSD
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 16 16 16 16
Low Target Price Estimate 9 9 9 9
Mean Target Price Estimate 12 12 12 12
Standard Deviation 2.61 2.61 2.61 2.61
Date of Most Recent Estimate 05/22/18 05/22/18 05/22/18 05/22/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 5 5 5 5
Moderate Buy 2 2 2 2
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.41 1.41 1.41 1.41